UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Integrated digital error suppression for improved detection of circulating tumor DNA

Nature biotechnology, 2016-05, Vol.34 (5), p.547-555

2016

Volltextzugriff (PDF)

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

JNCI : Journal of the National Cancer Institute, 2013-05, Vol.105 (10), p.701-710

2013

Volltextzugriff (PDF)

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

The New England journal of medicine, 2008-04, Vol.358 (16), p.1663-1671

2008

Volltextzugriff (PDF)

Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer

Journal of clinical oncology, 2015-07, Vol.33 (21), p.2353-2360

2015

Volltextzugriff (PDF)

Comparison of younger and older breast cancer survivors and age‐matched controls on specific and overall quality of life domains

Cancer, 2014-08, Vol.120 (15), p.2237-2246

2014

Volltextzugriff (PDF)

Anti-vascular endothelial growth factor therapy in breast cancer: game over?

Journal of clinical oncology, 2015-01, Vol.33 (2), p.133-135

Sledge, George W

2015

Volltextzugriff (PDF)

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

Journal of clinical oncology, 2017-09, Vol.35 (25), p.2875-2884

2017

Volltextzugriff (PDF)

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199

Journal of clinical oncology, 2014-09, Vol.32 (27), p.2959-2966

2014

Volltextzugriff (PDF)

Post-traumatic growth among veterans in the USA: results from the National Health and Resilience in Veterans Study

Psychological medicine, 2015-01, Vol.45 (1), p.165-179

2015

Volltextzugriff (PDF)

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

The New England journal of medicine, 2018-07, Vol.379 (2), p.111-121

2018

Volltextzugriff (PDF)

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)

Journal of clinical oncology, 2022-03, Vol.40 (9), p.978-987

2022

Volltextzugriff (PDF)

Redefining the Target: Chemotherapeutics as Antiangiogenics

Journal of clinical oncology, 2001-02, Vol.19 (4), p.1195-1206

2001

Volltextzugriff (PDF)

Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors

British journal of cancer, 2024-11, Vol.131 (8), p.1328-1339

2024

Volltextzugriff (PDF)

Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial

Breast cancer research : BCR, 2021-08, Vol.23 (1), p.87-87, Article 87

2021

Volltextzugriff (PDF)

Rethinking the metastatic cascade as a therapeutic target

Nature reviews. Clinical oncology, 2011-06, Vol.8 (6), p.325-332

2011

Volltextzugriff (PDF)

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Clinical cancer research, 2015-11, Vol.21 (22), p.5082-5091

2015

Volltextzugriff (PDF)

Liquid biopsy enters the clinic — implementation issues and future challenges

Nature reviews. Clinical oncology, 2021-05, Vol.18 (5), p.297-312

2021

Volltextzugriff (PDF)

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update

Annals of surgical oncology, 2017-01, Vol.24 (1), p.38-51

2017

Volltextzugriff (PDF)

Abemaciclib plus fulvestrant in East Asian women with HR+, HER2− advanced breast cancer: Overall survival from MONARCH 2

Cancer science, 2023-01, Vol.114 (1), p.221-226

2023

Volltextzugriff (PDF)

Targeted Therapy for Cancer in the Genomic Era

The cancer journal (Sudbury, Mass.), 2015-07, Vol.21 (4), p.294-298

2015

Volltextzugriff (PDF)

Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients

Breast cancer research : BCR, 2011-09, Vol.13 (5), p.R86-R86, Article R86

2011

Volltextzugriff (PDF)

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

Journal of clinical oncology, 2001-02, Vol.19 (3), p.843-850

2001

Volltextzugriff (PDF)

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

Journal of clinical oncology, 2008-09, Vol.26 (25), p.4063-4071

2008

Volltextzugriff (PDF)

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

Clinical cancer research, 2008-12, Vol.14 (24), p.8010-8018

2008

Volltextzugriff (PDF)

1 – 25 von 1.024

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(858)
Mit Volltextzugriff
(869)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.023)

Erscheinungsjahr

n.n

Thema

Science & Technology
(460)
Life Sciences & Biomedicine
(446)
Humans
(444)
Female
(309)
Oncology
(276)
Biological And Medical Sciences
(205)
Medical Sciences
(192)
Breast Neoplasms - Drug Therapy
(169)
Adult
(147)
Middle Aged
(146)
Breast Cancer
(130)
Aged
(124)
Breast Neoplasms - Pathology
(95)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(89)
Male
(86)
Pharmacology. Drug Treatments
(71)
Chemotherapy
(69)
Animals
(68)
Antineoplastic Agents
(67)
Gynecology. Andrology. Obstetrics
(64)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Integrated digital error suppression for improved detection of circulating tumor DNA

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer

Comparison of younger and older breast cancer survivors and age‐matched controls on specific and overall quality of life domains

Anti-vascular endothelial growth factor therapy in breast cancer: game over?

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199

Post-traumatic growth among veterans in the USA: results from the National Health and Resilience in Veterans Study

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial

Redefining the Target: Chemotherapeutics as Antiangiogenics

Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors

Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial

Rethinking the metastatic cascade as a therapeutic target

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Liquid biopsy enters the clinic — implementation issues and future challenges

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update

Abemaciclib plus fulvestrant in East Asian women with HR+, HER2− advanced breast cancer: Overall survival from MONARCH 2

Targeted Therapy for Cancer in the Genomic Era

Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

Suchergebnisse filtern